Author Correction: Reverse engineering synthetic antiviral amyloids (Nature Communications, (2020), 11, 1, (2832), 10.1038/s41467-020-16721-8)

Emiel Michiels, Kenny Roose, Rodrigo Gallardo, Ladan Khodaparast, Laleh Khodaparast, Rob van der Kant, Maxime Siemons, Bert Houben, Meine Ramakers, Hannah Wilkinson, Patricia Guerreiro, Nikolaos Louros, Suzanne J.F. Kaptein, Lorena Itatí Ibañez, Anouk Smet, Pieter Baatsen, Shu Liu, Ina Vorberg, Guy Bormans, Johan NeytsXavier Saelens, Frederic Rousseau, Joost Schymkowitz

Research output: Contribution to journalComment/debatepeer-review

Abstract

Correction to: Nature Communications, published online 05 June 2020 In this article the grant number G045920N relating to Funds for Scientific Research Flanders was omitted. The original article has been corrected.

Original languageEnglish (US)
Article number3492
JournalNature communications
Volume14
Issue number1
DOIs
StatePublished - Dec 2023
Externally publishedYes

ASJC Scopus subject areas

  • General Chemistry
  • General Biochemistry, Genetics and Molecular Biology
  • General Physics and Astronomy

Fingerprint

Dive into the research topics of 'Author Correction: Reverse engineering synthetic antiviral amyloids (Nature Communications, (2020), 11, 1, (2832), 10.1038/s41467-020-16721-8)'. Together they form a unique fingerprint.

Cite this